Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Incidence of Opioid Overdose Among Patients Using ER/LA Opioid Analgesics Before and After Implementation of the Class-Wide Opioid Risk Evaluation and Mitigation Strategy.

Esposito DB, Cepeda MS, Holick CN, Knox C, Desai VC, Liu N, Vojjala SK, Lyons JG, Wedin GP, Lanes S; REMS Program Companies Metrics Subteam.

J Pain Res. 2020 Jan 16;13:157-169. doi: 10.2147/JPR.S219324. eCollection 2020.

2.

Development and Validation of an Algorithm to Identify Endometrial Adenocarcinoma in US Administrative Claims Data.

Esposito DB, Banerjee G, Yin R, Russo L, Goldstein S, Patsner B, Lanes S.

J Cancer Epidemiol. 2019 Nov 3;2019:1938952. doi: 10.1155/2019/1938952. eCollection 2019.

3.

Testosterone Therapy in Relation to Prostate Cancer in a U.S. Commercial Insurance Claims Database.

Cook MB, Beachler DC, Parlett LE, Cochetti PT, Finkle WD, Lanes S, Hoover RN.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):236-245. doi: 10.1158/1055-9965.EPI-19-0619. Epub 2019 Oct 22.

PMID:
31641011
4.

Medical record-based ascertainment of behaviors suggestive of opioid misuse, diversion, abuse, and/or addiction among individuals showing evidence of doctor/pharmacy shopping.

Esposito DB, Cepeda MS, Lyons JG, Yin R, Lanes S; Members of the Opioid Post-Marketing Consortium Observational Studies Working Group.

J Pain Res. 2019 Jul 24;12:2291-2303. doi: 10.2147/JPR.S203350. eCollection 2019.

5.

Development of predictive models to identify advanced-stage cancer patients in a US healthcare claims database.

Esposito DB, Russo L, Oksen D, Yin R, Desai VCA, Lyons JG, Verpillat P, Peñalvo JL, Lamy FX, Lanes S.

Cancer Epidemiol. 2019 Aug;61:30-37. doi: 10.1016/j.canep.2019.05.006. Epub 2019 May 22.

PMID:
31128428
6.

Validation of an Algorithm for Claims-based Incidence of Prostate Cancer.

Parlett LE, Beachler DC, Lanes S, Hoover RN, Cook MB.

Epidemiology. 2019 May;30(3):466-471. doi: 10.1097/EDE.0000000000001007.

PMID:
30829831
7.

Incidence of outcomes relevant to vaccine safety monitoring in a US commercially-insured population.

Esposito D, Titievsky L, Beachler DC, Hawes JCL, Isturiz R, Scott DA, Gangemi K, Maroko R, Hall-Murray CK, Lanes S.

Vaccine. 2018 Dec 18;36(52):8084-8093. doi: 10.1016/j.vaccine.2018.10.052. Epub 2018 Nov 15.

8.

Predictive model algorithms identifying early and advanced stage ER+/HER2- breast cancer in claims data.

Beachler DC, de Luise C, Yin R, Gangemi K, Cochetti PT, Lanes S.

Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):171-178. doi: 10.1002/pds.4681. Epub 2018 Nov 9.

PMID:
30411431
9.

Development and Validation of an Algorithm for Identifying Patients with Hemophilia A in an Administrative Claims Database.

Lyons J, Desai V, Xu Y, Ridgeway G, Finkle W, Solari P, Sullivan S, Lanes S.

Value Health. 2018 Sep;21(9):1098-1103. doi: 10.1016/j.jval.2018.03.008. Epub 2018 May 7.

10.

Patient and prescriber characteristics among patients with type 2 diabetes mellitus continuing or discontinuing sulfonylureas following insulin initiation: data from a large commercial database.

Beachler DC, Fernandes G, Deshpande G, Jemison J, Lyons JG, Lanes S, Liu J, McNeill A.

Curr Med Res Opin. 2018 Jun;34(6):1061-1069. doi: 10.1080/03007995.2017.1416348. Epub 2018 Jan 5.

PMID:
29264933
11.

Risk of severe acute liver injury among patients with brain cancer treated with temozolomide: a nested case-control study using the healthcore integrated research database.

Desai VCA, Quinlan SC, Deitz AC, He J, Holick CN, Lanes S.

J Neurooncol. 2017 Aug;134(1):89-95. doi: 10.1007/s11060-017-2489-6. Epub 2017 Jul 17.

PMID:
28717885
12.

The feasibility of using multiple databases to study rare outcomes: the potential effect of long-acting beta agonists with inhaled corticosteroid therapy on asthma mortality.

Johannes CB, McQuay LJ, Midkiff KD, Calingaert B, Andrews EB, Tennis P, Brown JS, Camargo CA Jr, DiSantostefano RL, Rothman KJ, Stürmer T, Lanes S, Davis KJ.

Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):446-458. doi: 10.1002/pds.4151. Epub 2016 Dec 21.

PMID:
28000298
13.

Identifying health outcomes in healthcare databases.

Lanes S, Brown JS, Haynes K, Pollack MF, Walker AM.

Pharmacoepidemiol Drug Saf. 2015 Oct;24(10):1009-16. doi: 10.1002/pds.3856. Epub 2015 Aug 18. Review.

PMID:
26282185
14.

Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.

Esposito DB, Lanes S, Donneyong M, Holick CN, Lasky JA, Lederer D, Nathan SD, O'Quinn S, Parker J, Tran TN.

Am J Respir Crit Care Med. 2015 Nov 15;192(10):1200-7. doi: 10.1164/rccm.201504-0818OC.

PMID:
26241562
15.

Occurrence of adverse events among patients with inflammatory bowel disease in the HealthCore Integrated Research Database.

McAuliffe ME, Lanes S, Leach T, Parikh A, Faich G, Porter J, Holick C, Esposito D, Zhao Y, Fox I.

Curr Med Res Opin. 2015;31(9):1655-64. doi: 10.1185/03007995.2015.1065242. Epub 2015 Aug 20.

PMID:
26135040
16.

Incidence of stroke and seizure in Alzheimer's disease dementia.

Cook M, Baker N, Lanes S, Bullock R, Wentworth C, Arrighi HM.

Age Ageing. 2015 Jul;44(4):695-9. doi: 10.1093/ageing/afv061. Epub 2015 May 24.

PMID:
26008894
17.

Assessing bias in administrative database studies of RotaTeq vaccine completion due to exclusion of subjects with incomplete follow-up.

Lanes S, Quinlan SC, Mast TC, Greenland S, Holick CN.

Emerg Themes Epidemiol. 2015 Apr 18;12:5. doi: 10.1186/s12982-015-0027-6. eCollection 2015.

18.

Accuracy of administrative claims data to identify dose specific rotavirus vaccination information: Implications for studies of vaccine safety.

Quinlan SC, Lanes S, Holick CN, Mast TC.

Vaccine. 2015 May 21;33(22):2517-20. doi: 10.1016/j.vaccine.2015.04.009. Epub 2015 Apr 14.

PMID:
25887083
19.

A common data model to assess cardiovascular hospitalization and mortality in atrial fibrillation patients using administrative claims and medical records.

Panaccio MP, Cummins G, Wentworth C, Lanes S, Reynolds SL, Reynolds MW, Miao R, Koren A.

Clin Epidemiol. 2015 Jan 12;7:77-90. doi: 10.2147/CLEP.S64936. eCollection 2015.

20.

Dementia Coding, Workup, and Treatment in the VA New England Healthcare System.

Cho K, Gagnon DR, Driver JA, Altincatal A, Kosik N, Lanes S, Lawler EV.

Int J Alzheimers Dis. 2014;2014:821894. doi: 10.1155/2014/821894. Epub 2014 Feb 19.

21.

Role of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazine.

Russo L, Schneider G, Gardiner MH, Lanes S, Streck P, Rosen S.

Eur J Clin Pharmacol. 2014 Jun;70(6):709-17. doi: 10.1007/s00228-014-1660-7. Epub 2014 Mar 11.

22.

Response.

Lanes SF.

Chest. 2013 Nov;144(5):1736-1737. doi: 10.1378/chest.13-1733. No abstract available.

PMID:
24189877
23.

Comparative risk of bloodstream infection in hospitalized patients receiving intravenous medication by open, point-of-care, or closed delivery systems.

Mercaldi CJ, Lanes S, Bradt J.

Am J Health Syst Pharm. 2013 Jun 1;70(11):957-65. doi: 10.2146/ajhp120464.

PMID:
23686602
24.

Impact of health care payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the USA.

Schneider G, Juday T, Wentworth C 3rd, Lanes S, Hebden T, Seekins D.

AIDS Care. 2013;25(11):1470-6. doi: 10.1080/09540121.2013.774316. Epub 2013 Mar 21.

PMID:
23517139
25.

Ultrasound guidance decreases complications and improves the cost of care among patients undergoing thoracentesis and paracentesis.

Mercaldi CJ, Lanes SF.

Chest. 2013 Feb 1;143(2):532-538. doi: 10.1378/chest.12-0447.

PMID:
23381318
26.

Florbetaben PET in the Early Diagnosis of Alzheimer's Disease: A Discrete Event Simulation to Explore Its Potential Value and Key Data Gaps.

Guo S, Getsios D, Hernandez L, Cho K, Lawler E, Altincatal A, Lanes S, Blankenburg M.

Int J Alzheimers Dis. 2012;2012:548157. doi: 10.1155/2012/548157. Epub 2012 Dec 26.

27.

A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD.

Jara M, Wentworth C 3rd, Lanes S.

BMJ Open. 2012 May 22;2(3). pii: e000841. doi: 10.1136/bmjopen-2012-000841. Print 2012.

28.

Burden of illness in idiopathic pulmonary fibrosis.

Collard HR, Ward AJ, Lanes S, Cortney Hayflinger D, Rosenberg DM, Hunsche E.

J Med Econ. 2012;15(5):829-35. doi: 10.3111/13696998.2012.680553. Epub 2012 Apr 25.

PMID:
22455577
29.

Use of topical tretinoin and the development of noncutaneous adverse events: evidence from a systematic review of the literature.

Shapiro S, Heremans A, Mays DA, Martin AL, Hernandez-Medina M, Lanes S.

J Am Acad Dermatol. 2011 Dec;65(6):1194-201. doi: 10.1016/j.jaad.2010.10.014. Epub 2011 May 6. Review.

PMID:
21550137
30.

Incidence rates for thromboembolic, bleeding and hepatic outcomes in patients undergoing hip or knee replacement surgery.

Lanes S, Fraeman K, Meyers A, Wood Ives J, Huang HY.

J Thromb Haemost. 2011 Feb;9(2):325-32. doi: 10.1111/j.1538-7836.2010.04155.x.

31.

Evaluation of PvuII and XbaI polymorphisms in the estrogen receptor alpha gene (ESR1) in relation to menstrual cycle timing and reproductive parameters in post-menopausal women.

Silva IV, Rezende LC, Lanes SP, Souza LS, Madeira KP, Cerri MF, Paes MF, Daltoé RD, Chambô-Filho A, Guimarães MC, Graceli JB, Rangel LB.

Maturitas. 2010 Dec;67(4):363-7. doi: 10.1016/j.maturitas.2010.08.006. Epub 2010 Sep 29.

PMID:
20884142
32.

Baseline risk of gastrointestinal disorders among new users of meloxicam, ibuprofen, diclofenac, naproxen and indomethacin.

Lanes SF, Rodrígeuz LA, Hwangg E.

Pharmacoepidemiol Drug Saf. 2000 Mar;9(2):113-7. doi: 10.1002/(SICI)1099-1557(200003/04)9:2<113::AID-PDS478>3.0.CO;2-2.

PMID:
19025810
33.

The INSPIRE study: influence of prior use and discontinuation of inhaled corticosteroids.

Lanes SF, Jara M.

Am J Respir Crit Care Med. 2008 Sep 1;178(5):543-4; author reply 544. No abstract available.

PMID:
18713851
34.

Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation.

Greenland S, Lanes S, Jara M.

Clin Trials. 2008;5(1):5-13. doi: 10.1177/1740774507087703.

PMID:
18283074
35.

Comparative safety of long-acting inhaled bronchodilators: a cohort study using the UK THIN primary care database.

Jara M, Lanes SF, Wentworth C 3rd, May C, Kesten S.

Drug Saf. 2007;30(12):1151-60.

PMID:
18035867
36.

Cardiovascular and respiratory hospitalizations and mortality among users of tiotropium in Denmark.

de Luise C, Lanes SF, Jacobsen J, Pedersen L, Sørensen HT.

Eur J Epidemiol. 2007;22(4):267-72. Epub 2007 Mar 7.

PMID:
17342451
37.

Pooled clinical trial analysis of tiotropium safety.

Kesten S, Jara M, Wentworth C, Lanes S.

Chest. 2006 Dec;130(6):1695-703.

PMID:
17166984
38.

Chronic obstructive pulmonary disease severity and cardiovascular outcomes.

Curkendall SM, Lanes S, de Luise C, Stang MR, Jones JK, She D, Goehring E Jr.

Eur J Epidemiol. 2006;21(11):803-13. Epub 2006 Nov 15.

PMID:
17106760
39.
40.

COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.

Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD.

Chest. 2005 Oct;128(4):2068-75.

PMID:
16236856
41.

Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.

Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E Jr, She D.

Ann Epidemiol. 2006 Jan;16(1):63-70. Epub 2005 Jul 21.

PMID:
16039877
42.

Respiratory medications and the risk of cardiac arrhythmias.

Huerta C, Lanes SF, García Rodríguez LA.

Epidemiology. 2005 May;16(3):360-6.

PMID:
15824553
43.

The reporting odds ratio and its advantages over the proportional reporting ratio.

Rothman KJ, Lanes S, Sacks ST.

Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):519-23. Review.

PMID:
15317031
44.

Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam.

Singh G, Lanes S, Triadafilopoulos G.

Am J Med. 2004 Jul 15;117(2):100-6.

PMID:
15234645
45.

A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients.

Stern JO, Robinson PA, Love J, Lanes S, Imperiale MS, Mayers DL.

J Acquir Immune Defic Syndr. 2003 Sep;34 Suppl 1:S21-33.

PMID:
14562855
46.

Response to Ringbaek et al.

Lanes S.

Respir Med. 2003 Oct;97(10):1158. No abstract available.

47.

Ipratropium and lung health study.

Lanes S, Golisch W, Mikl J.

Am J Respir Crit Care Med. 2003 Mar 1;167(5):801; author reply 801-2. No abstract available.

PMID:
12598223
48.

Respiratory medications and risk of asthma death.

Lanes SF, García Rodríguez LA, Huerta C.

Thorax. 2002 Aug;57(8):683-6.

49.

Risk factors for death from asthma.

Lanes SF, Wilson JD.

Thorax. 2000 Jan;55(1):91. No abstract available.

50.

Biological interpretation of relative risk.

Lanes SF.

Drug Saf. 1999 Aug;21(2):75-9. Review.

PMID:
10456376

Supplemental Content

Support Center